Matthew Brams
CIK: 0001884361
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cingulate Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 16, 2026CING
Cingulate Inc.
Award(A)DirectStock Option (right to Buy)
26.4K shares- - Jul 16, 2026CING
Cingulate Inc.
Award(A)DirectStock Option (right to Buy)
53.6K shares- - Mar 9, 2026CING
Cingulate Inc.
Award(A)Direct4.5K shares- - Mar 9, 2026CING
Cingulate Inc.
Tax Payment(F)Direct1K shares- - Feb 6, 2026CING
Cingulate Inc.
Purchase(P)Direct1.9K shares at avg. $5.04$10K - Jul 7, 2025CING
Cingulate Inc.
Award(A)DirectStock Option (right to Buy)
52.5K shares- - Feb 18, 2025CING
Cingulate Inc.
Award(A)DirectStock Option (right to Buy)
17.6K shares- - Jan 17, 2025CING
Cingulate Inc.
Award(A)DirectStock Option (right to Buy)
2.7K shares- - Dec 31, 2024CING
Cingulate Inc.
Award(A)DirectStock Option (right to Buy)
1K shares- - Sep 30, 2024CING
Cingulate Inc.
Award(A)DirectStock Option (right to Buy)
1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 | CING Cingulate Inc. | Award(A) Stock Option (right to Buy) | 26,400 | - | - | Direct |
| Jul 16, 2026 | CING Cingulate Inc. | Award(A) Stock Option (right to Buy) | 53,600 | - | - | Direct |
| Mar 9, 2026 | CING Cingulate Inc. | Award(A) | 4,526 | - | $0 | Direct |
| Mar 9, 2026 | CING Cingulate Inc. | Tax Payment(F) | 1,025 | - | $0 | Direct |
| Feb 6, 2026 | CING Cingulate Inc. | Purchase(P) | 1,946 | $5.04 | $9,808 | Direct |
| Jul 7, 2025 | CING Cingulate Inc. | Award(A) Stock Option (right to Buy) | 52,500 | - | - | Direct |
| Feb 18, 2025 | CING Cingulate Inc. | Award(A) Stock Option (right to Buy) | 17,630 | - | - | Direct |
| Jan 17, 2025 | CING Cingulate Inc. | Award(A) Stock Option (right to Buy) | 2,748 | - | - | Direct |
| Dec 31, 2024 | CING Cingulate Inc. | Award(A) Stock Option (right to Buy) | 1,000 | - | - | Direct |
| Sep 30, 2024 | CING Cingulate Inc. | Award(A) Stock Option (right to Buy) | 1,000 | - | - | Direct |
1-10 of 10 transactions
About Brams Matthew
Brams Matthew (SEC CIK 0001884361) files insider reports with the SEC as EVP and Chief Medical Officer of Cingulate Inc. (CING).
Signal8 holds 8 ownership filings by Brams Matthew, all Form 4s, filed between Oct 1, 2024 and Jul 20, 2026. Those filings report 10 transactions, from Sep 30, 2024 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Brams Matthew's filings is in KANSAS CITY, KS.
Recent filings by Brams Matthew
- Jul 16, 2026: Grants or awards of CING derivative securities (2 lines, Form 4, code A).
- Mar 9, 2026: Grant or award of CING shares (Form 4, code A).
- Mar 9, 2026: Tax withholding of CING shares (Form 4, code F).
- Feb 6, 2026: Open-market purchase of CING shares (Form 4, code P).
- Jul 7, 2025: Grant or award of CING derivative securities (Form 4, code A).
Other insiders filing for Cingulate Inc. (CING)
- Silva Raul R., EVP and CSO
- Schaffer Shane J., Chief Executive Officer
- Downey Bryan Wade, EVP & Chief Commercial Officer
- Lawrence Bryan Jay, Director
- Hargroves Thomas Jeffrey, Director
- Callahan Jennifer L., EVP and CFO